These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs. Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053 [TBL] [Abstract][Full Text] [Related]
5. Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription. Zeller J; Turbiak AJ; Powelson IA; Lee S; Sun D; Showalter HD; Fearon ER Bioorg Med Chem Lett; 2013 Nov; 23(21):5814-20. PubMed ID: 24060489 [TBL] [Abstract][Full Text] [Related]
6. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression. Usongo M; Li X; Farookhi R Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518 [TBL] [Abstract][Full Text] [Related]
7. Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction. Wang Z; Zhang M; Wang J; Ji H J Med Chem; 2019 Apr; 62(7):3617-3635. PubMed ID: 30856332 [TBL] [Abstract][Full Text] [Related]
8. Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling. Qiang YW; Hu B; Chen Y; Zhong Y; Shi B; Barlogie B; Shaughnessy JD Blood; 2009 Apr; 113(18):4319-30. PubMed ID: 19196662 [TBL] [Abstract][Full Text] [Related]
9. Targeting the interaction of β-catenin and TCF/LEF transcription factors to inhibit oncogenic Wnt signaling. Koelman EMR; Yeste-Vázquez A; Grossmann TN Bioorg Med Chem; 2022 Sep; 70():116920. PubMed ID: 35841828 [TBL] [Abstract][Full Text] [Related]
10. Targeted β-catenin ubiquitination and degradation by multifunctional stapled peptides. Wang X; Dong L; Cheng J; Verdine GL; Lin A; Chu Q J Pept Sci; 2022 Jul; 28(7):e3389. PubMed ID: 34937123 [TBL] [Abstract][Full Text] [Related]
11. Cell-based assay for low- and high-scale screening of the Wnt/β-catenin signaling modulators. Mazur M; Bujak A; Matloka M; Janowska S; Gunerka P; Bojarski L; Stanczak A; Klejman A; Bednarek A; Lamparska-Przybysz M; Wieczorek M Anal Biochem; 2015 Apr; 475():56-67. PubMed ID: 25659657 [TBL] [Abstract][Full Text] [Related]
12. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938 [TBL] [Abstract][Full Text] [Related]
13. Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer. Schneider JA; Craven TW; Kasper AC; Yun C; Haugbro M; Briggs EM; Svetlov V; Nudler E; Knaut H; Bonneau R; Garabedian MJ; Kirshenbaum K; Logan SK Nat Commun; 2018 Oct; 9(1):4396. PubMed ID: 30352998 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel role of ZMIZ2 protein in regulating the activity of the Wnt/β-catenin signaling pathway. Lee SH; Zhu C; Peng Y; Johnson DT; Lehmann L; Sun Z J Biol Chem; 2013 Dec; 288(50):35913-24. PubMed ID: 24174533 [TBL] [Abstract][Full Text] [Related]
15. Grafting Hydrophobic Amino Acids Critical for Inhibition of Protein-Protein Interactions on a Cell-Penetrating Peptide Scaffold. Nagano Y; Arafiles JVV; Kuwata K; Kawaguchi Y; Imanishi M; Hirose H; Futaki S Mol Pharm; 2022 Feb; 19(2):558-567. PubMed ID: 34958576 [TBL] [Abstract][Full Text] [Related]
16. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway. Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447 [TBL] [Abstract][Full Text] [Related]
17. Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. Gan XQ; Wang JY; Xi Y; Wu ZL; Li YP; Li L J Cell Biol; 2008 Mar; 180(6):1087-100. PubMed ID: 18347071 [TBL] [Abstract][Full Text] [Related]
18. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator. Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935 [TBL] [Abstract][Full Text] [Related]
19. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931 [TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells. Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]